Joseph Levy

9PUBLICATIONS
33CO-AUTHORS
Medical infection agents (incl. prions)Molecular medicineForensic epidemiologyToxicology (incl. clinical toxicology)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 11, 2026
The Use of Glucagon-Like Peptide 1 Agonists Among Non-Diabetics: Evidence From Medicare Part D.

Minji Kim, Kieran Allsop, Joseph F Levy

|Jan 26, 2026
The Cost-Effectiveness of Enoxaparin Compared with Aspirin for Thromboprophylaxis in Patients with Orthopaedic Trauma.

Joseph F Levy, Robert V O'Toole, Deborah M Stein

|Feb 21, 2024
Effect of Aspirin Versus Low-Molecular-Weight Heparin Thromboprophylaxis on Medication Satisfaction and Out-of-Pocket Costs: A Secondary Analysis of a Randomized Clinical Trial.

Nathan N O'Hara, Katherine P Frey, Deborah M Stein

|Feb 04, 2023
The influence of Medicare Part D on the list pricing of brand drugs.

Benedic N Ippolito, Joseph F Levy

|Jan 28, 2022
The 1-Year Economic Impact of Work Productivity Loss Following Severe Lower Extremity Trauma.

Joseph F Levy, Lisa Reider, Daniel O Scharfstein

Pageof 2